Tirzepatide
An educational overview of Tirzepatide, a dual receptor agonist investigated for appetite regulation, glucose metabolism, body composition, and cardiometabolic research.
Peptide Class
Dual AgonistCategory
Weight ManagementResearch Interest
Very HighTargets
GLP-1 / GIPResearch Snapshot
Overview
Tirzepatide is an investigational peptide that activates both GLP-1 and GIP receptors. Researchers study its effects on appetite signaling, metabolic regulation, insulin biology, and body composition.
Because it targets two complementary metabolic pathways, Tirzepatide has become one of the most extensively researched compounds in obesity and metabolic science.
How It Works
Tirzepatide simultaneously activates GLP-1 and GIP receptors. Scientists continue to investigate how these pathways interact to influence satiety, glucose regulation, caloric intake, and overall metabolic physiology.
Areas of Scientific Interest
Related Compounds
FAQ
What receptors does Tirzepatide target?
Tirzepatide is designed to activate GLP-1 and GIP receptors for research purposes.
Does Cloud Peptides provide dosing information?
No. Cloud Peptides does not provide dosage recommendations or administration guidance.
Is this article educational?
Yes. It summarizes publicly available scientific literature for educational purposes only.
External Resources
Research Use Only
This page is provided for educational purposes only.
Cloud Peptides does not provide medical advice, treatment recommendations, or dosage information.
All products are intended strictly for laboratory research purposes only and are not for human consumption.